gastroparesis glp 1 agonist GLP-1 and Anesthesia: Considerations and Cautions for CRNAs Gastroparesis: Symptoms, Causes, Diagnosis &
Description
In the subgroup analyses, human GLP-1 RAs, but not nonhuman GLP-1 RAs, reduced the risk of MACE in patients with HF (p interaction = 0.11)
FDA-approved semaglutide products (Ozempic, Wegovy, Rybelsus) are commercially available
Results The first cohort included 36082 GLP-1 receptor agonist users (median follow-up 1.3 years) and 234028 DPP-4 inhibitor users (median follow-up 1.7 years)
Ozempic can be difficult to get and isn't appropriate for everyone
Even more concerning
95% CI 0.94, 1.03)
